Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1 −/− Mice
- 10 May 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 95 (11)
Abstract
Hepatitis A virus (HAV) is a common cause of viral hepatitis. Iminosugar compounds block its replication in cultured cells by inhibiting the synthesis of gangliosides required for HAV cell entry but have not been tested for their ability to prevent or treat hepatitis A in vivo .Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI103083)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI131685)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI150095)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK123499)
This publication has 37 references indexed in Scilit:
- Increase in Hepatitis A Virus Infections — United States, 2013–2018MMWR. Morbidity and Mortality Weekly Report, 2019
- Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017Eurosurveillance, 2018
- Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter systemAntiviral Research, 2018
- Globalization and the Changing Epidemiology of Hepatitis A VirusCold Spring Harbor Perspectives in Medicine, 2018
- Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis ACold Spring Harbor Perspectives in Medicine, 2018
- Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and preventionJournal of Hepatology, 2018
- Hepatitis A virus and the origins of picornavirusesNature, 2014
- Molecular Biology and Inhibitors of Hepatitis A VirusMedicinal Research Reviews, 2013
- Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replicationAntiviral Research, 2013
- In vitro and ex vivo inhibition of hepatitis A virus 3C proteinase by a peptidyl monofluoromethyl ketoneBioorganic & Medicinal Chemistry, 1997